Good morning!

My last alert, MJWL, blasted up by 257% within 30 minutes of my alert. The alert before that, WRGL, flew to a 129% gain within 20 minutes following my alert.  This morning we are issuing an immediate alert on NOUV (Nouveau Life Pharmaceuticals), which closed Monday at $0.0085. Get ready for some explosive trading!

For the last few weeks NOUV has been trading just below the $0.01 mark, building a beautiful base and showing solid support. If we look back at the end of May, NOUV briefly traded 400% higher.  When interest comes into NOUV this thing moves and provides massive runs. Additionally there is major support here, few sellers, and we think the stage is set for a traders’ dream.  We believe a breakout at this level can push NOUV much higher and spark enough momentum to deliver triple digit gains for early investors – YES THAT’S CORRECT, GAINS MORE THAN 100%!   

From a stock perspective we think the stage is set for fireworks.  Adding to our excitement, we love the space NOUV is involved in — the all natural supplement market, which as everyone knows is enormous – an $86 billion market in the U.S. alone, slightly larger in Europe, and projected to exceed $240 billion worldwide by 2016. In Japan, 47% of the entire population consumes nutraceuticals.  The growth of nutritional supplements is attributed to several key trends all of which continue to increase, including an aging baby-boomer population, a growing concern regarding health in society at large, and an increasing attempt by many people to accomplish desirable therapeutic outcomes with reduced side effects when compared to other therapeutic agents, such as drugs.  This is a massive industry and NOUV is positioning itself to capture a good chunk of the market share!

NOUV’s business strategy is to provide consumers with natural alternatives to prescription drugs for a healthy life style, using the highest quality ingredients and striving to be the most customer-focused company in the industry.  NOUV’s specialty nutraceuticals combat a multitude of health issues including sexual health, weight loss, high cholesterol, digestive disorders, acne, bone health, and more. The company also offers every-day supplements for an overall boost to health.

Learn more about what NOUV is up to at the company’s website:  http://www.nlpnaturals.com

One of the NOUV product lines we are most exited about is “Azul” which targets erectile dysfunction, and you all know we’re talking about billions of dollars here alone.

From the company’s recent press release (http://finance.yahoo.com/news/nouveau-life-pharmaceuticals-nouv-launch-123000139.html) we learn:

“Azul Instant(tm) is an all-natural maleenhancement supplement for ED that works in as little as 5 minutes. The supplement’s effects can last up to 48 hours. Azul Instant(tm) is a doctor-recommended pharmaceutical grade supplement that produces no side effects and promotes a healthy sexual lifestyle. A dose of Azul Instant(tm) is one capsule. The supplement is offered in a 5-pack for $24.99 or a 24-pack for $74.99 and can be purchased by visiting the Nouveau Life online store.”

Azul is inexpensive compared to pharmaceutical alternatives that deal with the same thing, and I don’t mention those drugs by name, like that one that starts with a V and ends in an A so that my newsletter doesn’t get trapped in your internet provider’s spam box.  :)    Gigantic market here my friends.

NOUV CEO Melissa Walker says about Azul, “There has been tremendous interest in this ED product since its planned production was announced earlier this year. This is our cornerstone product and to have it now on the market makes us very optimistic about the future of Nouveau.”

It makes us optimistic also!

Here’s something else, StockTA.com, a leading provider of technical analysis, has an overall “bullish” opinion of NOUV.  Its opinion is based on a variety of key technical indicators that are currently positioned bullishly for the stock.  Check out StockTA yourself for more in-depth analysis.

So my friends, I think NOUV is an incredible opportunity for investors to take advantage of a potentially explosive situation just as the company is releasing game-changing products.

I am expecting an awesome week for NOUV and everything appears positioned perfectly for the stock to go through the roof. Complete your research as soon as possible and don’t let an opportunity like this pass you by.

Get ready for an amazing trading session!

Warm Regards

Jeff Mirkin

DISCLAIMER:

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: DamnGoodPennyPicks employees are not registered as Investment Advisers or broker-dealers. Full disclaimer can be read athttp://www.damngoodpennypicks.com/disclaimer.php.  The disclaimer is to be read and fully understood before using our site, or joining our email list. None of the materials herein constitute offers or solicitations to purchase or sell securities of the companies profiled and any decision to invest in any such company_or other financial decisions should not be made based upon the information provided herein. Instead DamnGoodPennyPicks strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. DamnGoodPennyPicks does not offer such advice or analysis, and further urges you to consult your own independent financial advisors. The report in this newsletter is provided solely for informational and entertainment purposes. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, projections or future events are not statements of historical fact and are “forward-looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those anticipated. DamnGoodPennyPicks may receive compensation for the issuance of this report which is an absolute conflict of interest in our ability to be unbiased. In any event, DamnGoodPennyPicks will never accept compensation in shares, restricted or free trading. Any and all compensation received in cash will always be disclosed. For this report, DamnGoodPennyPicks has received twenty thousand dol lars in compensation by Legacy Global Markets, Inc.  In preparing this publication, DamnGoodPennyPicks has relied upon information supplied by its customers, and press releases that it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this report but rather use the information contained in this newsletter as a starting point for doing additional independent research on the featured companies. The advertisements in this newsletter are believed to be reliable, however, DamnGoodPennyPicks and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. DamnGoodPennyPicks is not responsible for any claims made by the companies advertised herein. Although the information contained in this e-mail is believed to be reliable, we make no warranties as to the accuracy of the content of this e-mail, and expressly disclaim and accept no liability for how readers may choose to utilize this e-mail.